« Older Entries
Prosensa Wins Scrip 'Biotech Company of the Year' 2014 Award
Wednesday, December 3rd, 2014
Leiden, The Netherlands, Dec. 8, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA), the biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with a high unmet medical need [...]
LSP invests in Xeltis, a leading regenerative medicine company
Tuesday, December 2nd, 2014
Amsterdam, the Netherlands, December 2, 2014. LSP (Life Sciences Partners), a leading European investor in health care, announces its investment in Xeltis, a private Swiss/Dutch regenerative medicine company developin [...]
Leve de wetenschap
Thursday, November 27th, 2014
De Nederlandse wetenschap is top. Durfinvesteerder LSP schrijft het nog eens op zijn website: de verkoop van biotechbedrijf Prosensa ‘is weer een illustratie van het potentieel van de Nederlandse wetenschap’.
[...]
LSP invests in Curetis, a leading molecular diagnostics company
Monday, November 24th, 2014
Amsterdam, the Netherlands, 24 November 2014. LSP (Life Sciences Partners), a leading European investor in health care, announces its investment in Curetis, a private German molecular diagnostic company developing and [...]
« Older Entries